US Patent 12090482 Systems and methods for performing biological assays
Patent 12090482 was granted and assigned to Pfizer on September, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 19 Sep, 2024
Golden AI
Edits made to:
Infobox (+111 properties)
Article (+394 characters)
US Patent 12090482 Systems and methods for performing biological assays
Article
Patent abstract
Systems and methods for performing biological assays are provided herein. The systems and methods determine one or more characteristics of a nucleic acid amplification sample based on a modified optical property of the sample. The nucleic acid amplification sample is reacted with an optical property modifying reagent in a reaction chamber of within a sample preparation device.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Debkishore Mitra0
Frank B. Myers, III0
Ivan Krastev Dimov0
John Robert Waldeisen0
Date of Patent
September 17, 2024
0Patent Application Number
173425330
Date Filed
June 8, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12090482 Systems and methods for performing biological assays
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
